NEW YORK A gauge of global equity markets rose on Tuesday as a Wall Street benchmark neared its record high, lifted by hopes for fresh U.S. stimulus and signs of a growing American economy that spurred yields to climb and thrashed gold prices.
Hopes of steady economic recovery from the COVID-19 pandemic boosted sentiment, helping European stocks hit a near three-week high as automakers gained on a surge in China sales numbers.
The S&P 500 neared its Feb. 19 peak, when investors started dumping shares in anticipation of what proved to be the biggest U.S. economic slump since the Great Depression.
The dollar resumed its weeks-long decline against a basket of peers and the euro topped $1.18 as investors flocked to currencies that benefit from an improving global market outlook, while gold prices dived as expectations of a U.S. stimulus deal boosted risk appetite.
Spot gold prices fell over 5%, on track for the largest one-day drop in over seven years and silver plunged over 12.5%, also the largest drop since 2013.
Spot gold last dropped 5.3% to $1,919.96 an ounce.
U.S. producer prices increased by the most in more than 1-1/2 years in July, and the Labor Department’s producer price index for final demand rose 0.6%, driven by a surge in portfolio management fees and rising costs for gasoline.
The market believes the economy will grow and that the pandemic will be overcome, said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York.
“Short term, we’re going to get stimulus,” Ghriskey said. “Longer term is that we’re going to get through this virus. We’re going to have a vaccine eventually.”
MSCI’s benchmark for global equity markets rose 0.71% to 568.08, off just over 2% from its record, while Europe’s broad FTSEurofirst 300 index closed up 1.64% at 1,436.83.
On Wall Street, the Dow Jones Industrial Average rose 0.93%, the S&P 500 gained 0.33% and the Nasdaq Composite dropped 0.45%. The S&P was less than half a percentage point from a fresh record.
Russian President Vladimir Putin’s announcement that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing aided sentiment, some analysts said.
“I’m not sure people put a lot of credence in the Russian vaccine, which hasn’t been tested,” Ghriskey said. “But who knows? Treatments are getting better and the economy is slowly improving.”
Benchmark 10-year notes last fell 24/32 in price to yield 0.6515%, from 0.574% late on Monday.
Sterling and commodity-linked currencies such as the Australian and Canadian dollars, as well as the Norwegian crown, gained against a broadly weakening dollar.
The euro rose 0.19%, to $1.1758. The dollar index fell 0.111%, and the Japanese yen weakened 0.60% versus the greenback at 106.58 per dollar.
(GRAPHIC: World stocks market cap – https://fingfx.thomsonreuters.com/gfx/mkt/jbyvrkazjpe/Pasted%20image%201597134060609.png)
(GRAPHIC: German vs US real yields – https://fingfx.thomsonreuters.com/gfx/mkt/azgpokdoqpd/Pasted%20image%201597133773753.png)
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
Comments
0 comment